five
distinct
cov
sarscov
caus
respiratori
tract
ill
human
rang
mild
common
cold
deadli
virusassoci
pneumonia
least
seven
differ
anim
cov
caus
econom
signific
epizoot
livestock
deadli
diseas
companion
anim
agent
sar
novel
cov
introduc
human
popul
anim
reservoir
result
highli
lethal
epidem
tremend
divers
cov
exist
complex
mammalian
avian
reservoir
host
switch
common
featur
cov
evolut
novel
epidem
cov
emerg
anytim
larg
divers
cov
complic
design
vaccin
identif
broadrang
anticov
drug
target
might
indic
altern
approach
cov
epidem
broad
rang
anticov
drug
would
also
desir
treat
sever
infect
caus
known
human
anim
cov
sarscov
genom
predict
encod
function
open
read
frame
lead
express
structur
nonstructur
protein
product
function
mani
protein
poorli
understood
unknown
studi
interplay
viral
protein
host
cell
identifi
new
target
involv
viral
replic
perform
genomewid
analysi
protein
protein
interact
sarscov
human
protein
via
highthroughput
yeast
two
hybrid
screen
within
framework
identifi
redund
interact
sarscov
nonstructur
protein
group
host
protein
peptidylprolyl
cistransisomeras
activ
includ
cyclophilinsimmunophilin
ppia
ppig
ppih
modul
calcineurinnfat
pathway
play
import
role
immun
cell
activ
nfat
famili
transcript
factor
encod
four
calciumregul
protein
three
express
varieti
cell
type
includ
tcell
bcell
mast
cell
natur
killer
cell
eosinophil
nfat
activ
regul
pivot
immun
process
like
apoptosi
anergi
tcell
develop
essenti
activ
step
nfat
dephosphoryl
phospatas
calcineurin
cna
result
transloc
nfat
nucleu
cyclosporin
cspa
form
complex
cyclophilin
bind
cna
prevent
activ
effect
use
transplant
patient
prevent
organ
reject
suppress
immun
system
show
sarscov
nonstructur
protein
well
full
replic
sarscov
enhanc
cnanfat
pathway
induc
nfatrespons
promot
interact
upstream
element
pathway
redundantli
identifi
hypothesisfre
virushost
interact
screen
pathway
like
play
signific
role
viru
replic
inde
extens
panel
cov
cover
three
relev
viru
genera
strongli
inhibit
manipul
cyclophilin
use
cspa
sarscov
orf
number
subfrag
lack
transmembran
region
clone
eukaryot
express
vector
use
screen
cdna
librari
high
complex
deriv
human
brain
well
addit
librari
individuallyclon
fulllength
orf
encod
human
protein
insert
posit
yeast
clone
sequenc
compar
genbank
blast
search
dna
sequenc
yield
differ
human
gene
hit
divid
four
confid
categori
categori
highli
confid
interact
partner
found
one
sever
screen
categori
b
singl
hit
categori
c
sticki
prey
interact
sever
mani
bait
protein
categori
cdna
region
insert
revers
orient
code
unnatur
peptid
found
hit
categori
respect
valid
cdna
categori
categori
b
interact
candid
clone
infram
renilla
reniformi
luciferas
overexpress
hek
cell
sarscov
orf
clone
infram
ntermin
protein
domain
coexpress
cell
protein
adirect
immunoprecipit
retain
iggcoat
magnet
bead
identifi
measur
invitro
luciferas
activ
categori
candid
categori
b
candid
confirm
posit
zscore
figur
see
materi
method
definit
correspond
previou
observ
list
valid
categori
b
interactor
candid
provid
tabl
overal
estim
plausibl
medlin
abstract
mention
sar
coronaviru
screen
use
text
mine
program
syngrep
scan
mention
human
protein
design
synonym
abstract
mention
yth
coimmunoprecipit
assay
specif
sought
twentyeight
covhost
protein
interact
identifi
literatur
list
tabl
determin
literatur
hit
overlap
list
candid
interactor
identifi
screen
differ
confid
level
use
hypergeometr
test
fraction
overlap
compar
fraction
literatur
hit
list
search
term
human
protein
use
textmin
abstract
enrich
protein
identifi
sarscov
interact
partner
high
confid
complet
data
set
tabl
tabl
figur
summar
highli
confid
interact
identifi
overal
screen
go
analysi
sarscov
protein
found
preferenti
target
protein
complex
subunit
tabl
tabl
complex
target
subunit
complex
found
significantli
enrich
respiratori
chain
complex
subunit
target
sarscov
pvalu
cytoplasm
ribosom
subunit
target
sarscov
pvalu
particular
ribosom
subunit
subunit
target
sarscov
pvalu
lcrassoci
remodel
complex
involv
dna
conform
modif
subunit
target
sarscov
pvalu
furthermor
analysi
central
sar
target
within
human
interact
network
figur
indic
sarscov
protein
target
highli
interact
protein
hub
well
socal
bottleneck
protein
central
mani
shortest
path
network
figur
tabl
summar
go
result
sarscov
nonstructur
protein
protein
yield
particularli
interest
candid
interact
network
interact
sever
member
class
immunophilin
ppia
ppig
ppih
protein
b
calcipressin
select
experiment
confirm
immunophilin
protein
cyclophilin
protein
known
bind
cna
combin
inhibitori
molecul
influenc
cnanfat
pathway
play
major
role
establish
tcell
immun
respons
detail
map
hit
ppia
ppib
ppig
ppih
three
version
aa
aa
aa
clone
lumier
assay
vector
yield
luciferas
protein
fusion
protein
respect
although
ppib
identifi
interactor
includ
experi
known
bind
gag
protein
hcv
protein
test
protein
interact
aa
suggest
redund
interact
sarscov
cnanfat
pathway
via
ntermin
part
figur
examin
function
consequ
express
nfat
activ
nfat
cna
cdna
overexpress
hek
cell
parallel
experi
jurkat
cell
done
without
overexpress
due
constitut
activ
cnanfat
pathway
cnanfat
pathway
stimul
addit
pma
ngml
ionomycin
cultur
medium
cell
line
treat
way
express
induc
nfat
activ
directli
increas
significantli
stimulatori
effect
pmaionomycin
nfat
activ
figur
increas
nfat
activ
could
block
cspa
inhibitor
nfat
pathway
figur
b
coexpress
calcipressin
shown
figur
attenu
overal
stimul
effect
nfat
activ
contrast
coexpress
cov
protein
coexpress
ppia
ppih
impact
nfat
activ
data
shown
experi
point
employ
overexpress
differ
nfat
speci
express
depend
cell
type
altern
express
compar
assay
speci
essenti
influenc
pmaionomycindepend
stimul
seen
figur
altogeth
suggest
broad
effect
nfat
activ
mediat
via
canon
nfat
activ
pathway
includ
cna
order
determin
extent
pmaionomycindepend
nfat
activ
viru
infect
hek
lp
cell
lp
low
passag
short
passag
histori
infect
sarscov
moi
cell
previous
demonstr
support
sarscov
replic
contrast
common
hek
cell
figur
show
cnanfat
pathway
induc
context
sarscov
infect
consider
extent
pmaionomycindepend
way
virus
may
interfer
cytokin
induct
hand
may
also
induc
cytokin
gene
directli
examin
whether
pmaionomycindepend
activ
nfat
may
caus
specif
induct
relev
cytokin
cell
cotransfect
plasmid
describ
except
nfat
report
plasmid
replac
luciferas
report
plasmid
carri
promot
respect
figur
express
induc
promot
significantli
factor
figur
effect
inhibit
cspa
suggest
depend
cnanfat
pathway
promot
activ
significantli
elev
express
presenc
pmaionomycin
figur
activ
decreas
presenc
cspa
promot
induc
pmaionomycin
alon
significantli
downregul
factor
addit
presenc
figur
express
reduc
promot
activ
level
half
cspa
inhibit
promot
complet
jurkat
cell
express
endogen
cna
protein
induc
promot
slight
induct
downregul
promot
activ
presenc
twofold
similar
effect
seen
hek
cell
result
suggest
express
strongest
influenc
promot
next
nfat
transcript
factor
activ
protein
determin
regul
nfat
bind
site
juxtapos
promot
shown
nfat
act
cooper
manner
promot
nfkb
enhanc
function
simultan
induc
ifnbeta
gene
bind
prdii
dna
element
latter
sensit
assay
nuclear
transloc
upon
viral
infect
examin
potenti
direct
effect
nuclear
transloc
hek
jurkat
cell
cotransfect
sarscov
contain
repeat
prdii
element
contain
bind
site
promot
figur
overexpress
well
treatment
pmaionomycin
respect
caus
small
signific
luciferas
increas
cell
line
combin
express
pmaionomycin
treatment
led
signific
induct
prdii
factor
cell
line
promotor
slightli
upregul
downregul
jurkat
cell
indic
coinvolv
induct
suggest
depend
mainli
nfat
pathway
summari
sarscov
caus
relev
specif
induct
activ
nfat
pathway
via
cspa
highli
effici
antagonist
nfat
activ
interact
cyclophilin
due
high
specif
activ
nfat
due
high
redund
sarscov
interact
upstream
element
cnanfat
pathway
suspect
essenti
function
viru
therefor
investig
whether
cspa
might
influenc
viral
replic
figur
vero
cell
inocul
low
dose
sarscov
moi
growth
viru
replic
determin
realtim
rtpcr
plaqu
titrat
parallel
cell
cultur
treat
concentr
cspa
cell
viabil
measur
highli
sensit
assay
base
atp
provis
metabol
activ
cell
profound
dosedepend
inhibit
replic
sarscov
strain
vero
cell
seen
absenc
cytopath
effect
confer
compound
effect
inhibitori
concentr
protein
group
sar
coronavirus
share
structur
function
similar
test
whether
inhibitori
effect
cspa
could
extend
pathogen
cov
includ
member
genera
alphacoronaviru
human
felin
cov
serotyp
ii
strain
black
porcin
transmiss
gastroenter
viru
tgev
betacoronaviru
sarscov
isol
frankfurt
hongkong
gammacoronaviru
avian
infecti
bronchiti
viru
ibv
test
cov
inhibit
cspa
replic
tgev
ibv
test
rang
diminish
close
background
cspa
two
felin
cov
serotyp
complet
inhibit
effect
concentr
respect
figur
figur
show
reduct
viru
replic
log
scale
order
determin
princip
stage
cov
replic
cycl
inhibit
cspa
novel
sarscov
replicon
carri
secret
metridia
luciferas
report
construct
instead
major
structur
protein
e
use
figur
replicon
rna
togeth
mrna
nucleocapsid
protein
electropor
bhk
cell
replicon
activ
parallel
reaction
control
level
h
incub
data
shown
increas
amount
cspa
ad
cell
repeat
wash
shown
figur
accumul
luciferas
activ
supernat
decreas
cspa
dosedepend
manner
h
two
differ
specif
inhibitor
cov
main
proteas
cinanserin
r
h
unpublish
observ
inhibit
replicon
activ
compar
extent
cspa
compar
substanc
concentr
figur
control
influenc
nucleocapsid
protein
coelectropor
maxim
replicon
effici
also
contain
replicon
rna
protein
express
eukaryot
express
vector
cell
nfat
induct
assay
conduct
describ
ndepend
effect
assay
seen
figur
result
suggest
action
cspa
genom
replic
andor
transcript
rather
stage
viru
entri
egress
variou
genom
proteom
method
util
identifi
proteinprotein
interact
context
viral
replic
among
direct
approach
identifi
interact
member
viral
orfeom
larg
host
cdna
librari
major
advantag
method
includ
potenti
high
throughput
test
autom
well
high
sensit
latter
facilit
investig
protein
express
low
level
caus
weak
transient
interact
drawback
includ
inabl
control
confirm
express
gene
interest
posit
select
yeast
express
clone
contain
nutrit
marker
moreov
protein
need
posttransl
modif
provid
yeast
cell
order
interact
bind
partner
also
sinc
interact
bait
prey
protein
take
place
nucleu
yeast
cell
assay
influenc
hydrophob
transmembran
region
affect
nuclear
membran
well
known
consider
fraction
interact
protein
repres
fals
posit
find
make
absolut
necessari
valid
interact
independ
eukaryot
assay
implement
version
lumier
assay
amen
screen
mammalian
cell
medium
scale
parallel
modifi
version
use
protein
tag
instead
flag
tag
enabl
autom
captur
precipit
igg
fccoat
magnet
bead
throughput
mainli
limit
requir
subclon
plasmid
insert
assay
involv
cellbas
imag
readout
go
beyond
invitro
luciferas
assay
analysi
interact
partner
achiev
posit
confirm
rate
categori
b
interactor
good
agreement
recent
standard
comparison
five
differ
interact
assay
lumier
pulldown
assay
show
highest
sensit
posit
refer
set
human
protein
mention
interact
assay
system
carri
intrins
limit
case
modifi
lumier
method
renilla
protein
tag
rather
long
compar
ha
tag
therefor
true
interact
might
miss
possibl
interact
ppia
fulllength
steric
prevent
length
tag
compar
ntermin
fragment
chief
attract
method
applic
high
thoughput
assay
rang
interactor
identifi
studi
defin
unpreced
resourc
futur
investig
pathogenet
mechan
antivir
applic
cov
order
demonstr
afford
direct
identif
novel
antivir
target
chosen
one
promis
group
interactor
investig
present
studi
interact
cyclophilin
ppia
ppib
ppig
ppih
protein
cna
calcipressin
regul
repres
highli
redund
virushost
interact
involv
critic
element
regulatori
network
immedi
upstream
cnanfat
pathway
virul
factor
invivo
whose
action
link
earli
stage
immun
respons
includ
antagon
ifn
signal
inhibit
host
protein
synthesi
find
add
import
new
dimens
role
pathogen
identifi
protein
strong
specif
activ
nfat
enhanc
induct
promot
increas
nfat
activ
extend
three
major
nfat
speci
suggest
potenti
induct
broad
system
cytokin
dysregul
affect
sever
type
immun
cell
pattern
cytokin
dysregul
sever
sar
case
differ
cytokin
burst
seen
acut
viral
diseas
delay
occurr
manifest
beyond
second
week
symptom
interestingli
note
upon
clinic
observ
late
aggrav
correl
sever
clinic
outcom
trigger
parallel
effort
sever
center
treat
patient
empir
steroid
result
suggest
influenc
fundament
trigger
immun
cell
activ
contribut
explan
cytokin
dysregul
immunedepend
pathogenesi
observ
sever
case
sar
detect
interact
immunophilin
caught
attent
peptid
inhibitor
cspa
tacrolimu
avail
bind
immunophilin
caus
dramat
effect
cellular
phosphatas
cna
suppress
cnanfat
immuneregulatori
pathway
cyclophilin
essenti
cofactor
replic
hcv
hiv
parasit
incorpor
ppia
particl
via
bind
gag
parallel
bind
n
protein
sarscov
educ
guess
find
use
surfac
plasmon
reson
biosensor
technolog
furthermor
recent
proteom
studi
viral
cellular
protein
incorpor
sarscov
virion
spectrometr
profil
ppia
also
found
purifi
viru
particl
inde
shown
inhibit
cyclophilin
cspa
exhibit
strong
specif
inhibitori
effect
member
three
genera
cov
broad
antivir
action
support
recent
character
structur
conserv
extend
beyond
limit
cov
genera
inhibit
took
place
low
micromolar
rang
indic
prospect
futur
investig
similar
nonimmunosuppress
drug
broadrang
antivir
drug
alreadi
employ
hcv
whose
nonstructur
protein
interact
cyclophilin
whose
replic
inhibit
cspa
nonimmunosuppress
deriv
thereof
studi
limit
clarifi
biolog
function
interact
cellular
partner
confirm
involv
full
viru
context
knock
experi
recombin
virus
brockway
denison
show
delet
residu
aminotermin
half
toler
product
infect
thu
seem
possibl
construct
virus
mutat
n
termin
half
bind
cyclophilin
anymor
thereofor
difficult
exactli
delin
role
virushost
cooper
also
appreci
cspainhibit
nfat
induct
sarscov
may
independ
replic
inhibit
cspa
cspa
specif
bind
cyclophilin
complex
bind
calcineurin
phosphatas
prevent
dephosphoryl
nfat
bind
cyclophilin
induct
nfat
obvious
inhibit
csp
independ
level
format
cyclophilincspa
complex
might
prevent
cyclophilin
function
requir
viru
replic
complex
studi
involv
multipl
cov
system
requir
delin
function
nevertheless
abl
shed
light
princip
stage
viru
replic
cycl
subject
cspadepend
inhibit
experi
use
sarscov
replicon
suggest
strongli
process
afford
replic
protein
rather
stage
viru
entri
egress
affect
experi
need
done
futur
order
investig
mechanist
level
potenti
breadth
identifi
antivir
effect
particular
larg
divers
cov
anim
reservoir
gener
interest
studi
conserv
particular
virushost
interact
might
nonhuman
cov
human
cell
whether
could
exploit
truli
broadrang
antivir
target
cover
epidem
reservoirborn
virus
alik
low
passag
vero
hrt
huh
fcwf
stcell
grown
dulbecco
modifi
eagl
medium
dmem
contain
fb
lglutamin
penicillinstreptomycin
non
essenti
amino
acid
seap
cell
cultur
rpmi
medium
fb
penicillinstreptomycin
jurkat
cell
propag
rpmimedium
contain
fb
lglutamin
penicillinstreptomycin
clone
sar
orfeom
destin
bait
vector
screen
describ
previous
seri
sarscov
frankfurt
isol
bait
clone
contain
orf
fragment
deplet
transmembran
region
gener
addit
primer
clone
procedur
avail
request
autom
yeast
twohybrid
screen
essenti
done
describ
previous
follow
modif
human
cdna
librari
human
brain
fetal
brain
clontech
well
librari
individu
clone
open
read
frame
cdna
differ
gene
screen
minim
coverag
million
clone
per
librari
mate
yeast
strain
exponenti
grow
cultur
combin
pellet
centrifug
resuspend
equal
volum
ypda
yeast
extract
pepton
dextros
adenin
contain
peg
gener
highconfid
dataset
interact
pair
select
isol
least
twice
bait
interact
two
highli
relat
prey
involv
promiscu
prey
lumier
assay
protein
transient
express
cell
ntermin
fusion
protein
staphylococcu
aureu
protein
tag
renilla
reniformi
luciferas
ng
express
construct
transfect
cell
use
lipofectamin
invitrogen
well
plate
hour
medium
remov
cell
lyse
ice
icecold
lysi
buffer
mm
tri
ph
mm
nacl
mm
edta
mm
dtt
proteas
inhibitor
cocktail
roch
phosphatas
inhibitor
cocktail
roch
benzonas
novagen
unit
per
final
concentr
contain
sheepantirabbit
iggcoat
magnet
bead
invitrogen
dynabead
mgml
final
concentr
lysat
incub
ice
minut
wash
buffer
pb
mm
dtt
ad
per
well
dilut
lysat
remov
determin
luciferas
activ
present
sampl
wash
rest
sampl
wash
time
wash
buffer
tecan
hydroflex
plate
washer
luciferas
activ
measur
lysat
well
wash
bead
neg
control
transfect
plasmid
express
luciferas
fusion
protein
vector
express
dimer
protein
sampl
four
valu
measur
luciferas
present
sampl
wash
luciferas
activ
present
bead
wash
valu
neg
control
normalis
interact
signal
calcul
follow
log
bound
log
input
log
bound
nc
log
input
nc
zscore
calcul
subtract
mean
divid
standard
deviat
mean
standard
deviat
calcul
larg
dataset
protein
pair
expect
interact
ie
neg
refer
set
normalis
signal
nois
ratio
calcul
follow
boundinput
bound
ncinput
nc
report
gene
express
cell
transient
transfect
dna
contain
ng
respect
express
plasmid
encod
nfat
calcineurin
sarscov
report
gene
indic
six
well
plate
dna
transfect
use
fugen
hd
reagent
roch
appli
scienc
report
gene
express
jurkat
cell
cell
report
plasmid
express
plasmid
encod
sarscov
transient
cotransfect
use
amaxa
cell
line
nucleofector
kit
lonza
report
gene
assay
viral
context
cell
plate
transient
transfect
ng
report
plasmid
use
lipofectamin
ltx
invitrogen
accord
manufactur
instruct
h
post
transfect
cell
infect
sarscov
hk
moi
h
transfect
cell
harvest
promega
dual
luciferas
assay
perform
accord
manufactur
instruct
result
normal
simultan
transfect
renilla
luciferas
prlnull
promega
cell
stimul
pma
ngml
ionomycin
cultur
medium
nfatpathway
inhibit
cyclosporin
ngml
viru
infect
cell
lyse
h
post
infect
promega
passiv
lysi
buffer
plb
igep
sigmaaldrich
experi
repeat
least
three
time
vero
cell
seed
plate
confluenc
cell
wash
phosphat
buffer
salin
pb
infect
moi
h
adsorpt
cell
wash
twice
pb
supplement
ml
fresh
media
inhibitor
differ
concentr
supernat
test
h
pi
h
pi
quantit
real
time
rtpcr
supernat
taken
analys
describ
previous
plaqu
titrat
vero
cell
perform
use
avicel
overlay
fmc
biopolym
belgium
describ
cell
seed
plate
quantit
real
time
rtpcr
cell
infect
moi
confluenc
h
adsorpt
viral
inoculum
remov
cell
wash
twice
pb
ml
fresh
medium
supplement
differ
inhibitor
concentr
ad
cell
supernat
test
day
day
pi
viral
rna
extract
cell
cultur
supernat
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
real
time
rtpcr
determin
viral
replic
plaqu
assay
done
describ
previous
variou
inhibitor
concentr
directli
ad
overlay
medium
cell
fix
plaqu
stain
crystal
violet
formaldehyd
ethanol
paraformaldehyd
cell
seed
plate
incub
monolay
confluent
cell
infect
v
thiel
unpublish
data
orf
replac
renilla
luciferas
moi
h
adsorpt
viral
inoculum
remov
cell
wash
pb
incub
ml
fresh
medium
contain
differ
inhibitor
concentr
viral
replic
determin
h
h
pi
renilla
luciferas
assay
system
promega
madison
usa
accord
manufactur
instruct
vero
cell
grown
plate
infect
ibv
beaudett
moi
methylcellulos
ad
h
incub
differ
concentr
cspa
rang
mix
methylcellulos
h
cell
fix
paraformaldehyd
plaqu
stain
antiibv
polyclon
serum
rais
rabbit
fitclabel
secondari
antibodi
st
cell
seed
plate
confluenc
cell
wash
twice
pb
infect
moi
plaqu
assay
perform
describ
previous
differ
inhibitor
concentr
directli
ad
overlay
media
one
day
experi
fcwf
cell
seed
plate
cell
infect
respect
viru
dilut
h
infect
cell
wash
ml
pb
ml
fresh
medium
differ
inhibitor
concentr
ad
h
pi
supernat
analyz
via
plaqu
assay
freshli
seed
fcwf
cell
confluenc
cell
infect
h
wash
ml
pb
ml
carboxymethylcellulos
medium
ad
cell
h
plaqu
analyz
vero
cell
seed
plate
infect
moi
h
infect
medium
remov
replac
fresh
medium
supplement
differ
inhibitor
concentr
h
pi
supernat
analyz
plaqu
titrat
freshli
seed
vero
cell
cell
infect
h
wash
ml
pb
incub
nobl
agar
difco
overlay
medium
h
fixat
ml
trichloro
acet
acid
tca
min
plaqu
stain
crystal
violet
formaldehyd
methanol
ethanol
seap
cell
seed
densiti
cell
per
cspa
ad
final
concentr
cultur
inocul
low
moi
allow
complet
inhibit
replic
presenc
hiv
proteas
inhibitor
nelfinavir
nfv
ensur
multipl
round
infect
half
cultur
medium
discard
day
replac
fresh
medium
inhibitor
replic
monitor
microscop
via
cytopath
effect
measur
day
via
activ
secret
alkalin
phosphatas
seap
cell
cultur
supernat
employ
phosphalight
seap
report
gene
assay
appli
biosystem
experi
outcom
mocktreat
cell
set
data
shown
mean
valu
least
three
experi
data
show
one
repres
experi
three
valu
averag
triplic
dmso
alway
ad
control
correspond
highest
inhibitor
concentr
cytotox
test
cell
line
carri
format
celltiterglo
luminesc
cell
viabil
assay
promega
madison
usa
accord
manufactur
instruct
sar
replicon
base
previous
pubish
infecti
sarscov
cdna
clone
pcr
mutagenesi
classic
clone
techniqu
orf
delet
replac
marker
gene
respect
orf
spike
gene
secret
metridia
luciferas
promega
insert
use
origin
transcriptionregul
sequenc
furthermor
potenti
select
gfpzeocin
fusion
protein
place
open
read
frame
clone
detail
given
author
upon
request
assay
perform
triplic
replicon
rna
n
rna
transcrib
electropor
bhk
cell
describ
inhibitor
assay
cell
seed
well
plate
electropor
use
cell
per
well
incub
hour
hereaft
supernat
remov
entir
cell
wash
twice
pb
ml
fresh
medium
indic
concentr
inhibitor
ad
timepoint
supernat
remov
luciferas
assay
promega
rlu
measur
recommend
manufactur
determin
cellular
pathway
target
sarscov
function
categori
enrich
among
sar
cellular
interact
partner
identifi
use
gene
ontolog
go
overrepresent
analysi
purpos
pvalu
determin
hypergeometr
test
implement
ontolog
softwar
pvalu
correct
multipl
test
use
fdrmethod
benjamini
hochberg
signific
term
identifi
threshold
analyz
whether
protein
involv
protein
complex
preferenti
target
sarscov
protein
complex
preferenti
target
purpos
protein
complex
human
extract
corum
databas
remov
complex
ident
anoth
complex
obtain
data
set
complex
contain
distinct
protein
pvalu
enrich
protein
complex
subunit
among
sar
target
calcul
hypergeometr
test
assum
background
protein
tabl
furthermor
analyz
complex
target
least
four
subunit
sar
protein
use
hypergeometr
test
determin
pvalu
enrich
sar
target
protein
among
subunit
complex
pvalu
correct
multipl
test
use
fdr
method
benjamini
hochberg
tabl
interact
sar
protein
human
protein
connect
network
human
proteinprotein
interact
taken
human
protein
refer
databas
hprd
releas
biolog
gener
repositori
interact
dataset
biogrid
databas
compar
distribut
degre
number
interact
between
central
viral
target
protein
human
network
kolmogorovsmirnov
test
r
pvalu
correct
multipl
test
use
fdrmethod
benjamini
hochberg
degre
between
central
altern
measur
network
central
individu
protein
high
degre
character
socal
hub
highli
interact
high
between
central
character
socal
bottleneck
central
mani
connect
protein
